1. Proportion of patients who either continue to be COVID positive by RT-PCR at Day 5. <br/ >OR <br/ >2. Suffer clinical deterioration by Day 10 from the date of randomization (excluding the date of randomization) in test arm as compared to control arm. <br/ >Timepoint: RT-PCR will be performed on day 5 after the 5th dose and the RT-PCR negative patients will be discharged on Day 6

1. Proportion of patients who either continue to be COVID positive by RT-PCR at Day 5. <br/ >OR <br/ >2. Suffer clinical deterioration by Day 10 from the date of randomization (excluding the date of randomization) in test arm as compared to control arm. <br/ >Timepoint: RT-PCR will be performed on day 5 after the 5th dose and the RT-PCR negative patients will be discharged on Day 6

N/A

N/A

1. Proportion of patients who either continue to be COVID positive by RT-PCR at Day 5. <br/ >OR <br/ >2. Suffer clinical deterioration by Day 10 from the date of randomization (excluding the date of randomization) in test arm as compared to control arm. <br/ >Timepoint: RT-PCR will be performed on day 5 after the 5th dose and the RT-PCR negative patients will be discharged on Day 6

1. Proportion of patients who either continue to be COVID positive by RT-PCR at Day 5. <br/ >OR <br/ >2. Suffer clinical deterioration by Day 10 from the date of randomization (excluding the date of randomization) in test arm as compared to control arm. <br/ >Timepoint: RT-PCR will be performed on day 5 after the 5th dose and the RT-PCR negative patients will be discharged on Day 6